| | BL1 | BL2 | LAR | M |
|---|
| Gender |
| Female | 100% | 100% | 100% | 100% |
| Age at Diagnosis |
| 20–29 | 2% | 3% | 13% | 5% |
| 30–39 | 7% | 6% | 8% | 30% |
| 40–49 | 39% | 24% | 39% | 34% |
| 50–59 | 21% | 41% | 21% | 20% |
| 60–69 | 18% | 12% | 13% | 7% |
| 70–79 | 9% | 9% | 3% | 5% |
| 80+ | 5% | 6% | 3% | 0% |
| Ethnicity |
| Not Hispanic or Latino | 82% | 88% | 87% | 89% |
| Hispanic or Latino | 2% | 12% | 5% | 2% |
| Not reported | 16% | 0% | 8% | 9% |
| Race |
| White | 51% | 65% | 66% | 64% |
| Black/African American | 32% | 32% | 26% | 32% |
| Asian | 7% | 3% | 8% | 5% |
| Not reported | 11% | 0% | 0% | 0% |
| Vital Status |
| Alive | 89% | 85% | 71% | 86% |
| Dead | 11% | 15% | 29% | 14% |
| Disease Type |
| Ductal or Lobular Neoplasm | 100% | 85% | 97% | 86% |
| Complex Epithelial Neoplasm | 0% | 15% | 0% | 7% |
| Epithelial Neoplasm, NOS | 0% | 0% | 0% | 5% |
| Fibroepithelial Neoplasm | 0% | 0% | 3% | 0% |
| Basal Cell Neoplasm | 0% | 0% | 0% | 2% |
- Distribution of available cases among demographic categories according to TNBC subtypes
